Carolina Longevity Institute

Carolina Longevity Institute appears to have been a private U.S. longevity-focused healthcare and research business operating under the CLI abbreviation. Historical descriptions characterize it as an Eli Global-affiliated company that invested in or pursued clinical-trial and product opportunities related to healthy aging and life-extension science, including areas such as GDF-11, CRISPR-Cas9, stem cells, NAD+ and telomere editing. More recent web evidence points to an active consumer-facing brand called Carolina Longevity in Chapel Hill, North Carolina offering physician-led longevity, hormone, metabolic-health, recovery and performance services, but the specific legal entity "Carolina Longevity Institute LLC" itself is not clearly evidenced as active today. Because publicly available information is sparse and partly inconsistent, the company is best understood as a private longevity-health business with limited verifiable pipeline disclosure rather than a conventional drug-development biotech.